Literature DB >> 8263145

Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency.

K Kamoi1, T Tamura, K Tanaka, M Ishibashi, T Yamaji.   

Abstract

To clarify the mechanism underlying abnormal vasopressin (AVP) secretion in glucocorticoid deficiency, we examined the response of AVP secretion to osmotic stimulus produced by 5% saline infusion and analyzed the possible causative factors in seven patients with hypoosmolal hyponatremia resulting from adrenal insufficiency. In all patients, urinary sodium excretion persisted with urine osmolality exceeding plasma osmolality, and plasma AVP levels relative to plasma osmolality were elevated. Blood urea nitrogen, plasma creatinine, and PRA ranged from low to normal. All patients had nausea or vomiting, three had hypotension, and two had hypoglycemia; however, the primary cause of increased AVP secretion was attributed to none of these stimuli. After 5% saline infusion, patterns of changes in plasma AVP levels in individual patients were variable: levels decreased with increasing plasma osmolality in two patients and remained unchanged in the other five patients. Despite hyponatremia and absence of hypovolemia, thirst was present in the five patients, who responded normally to questions. This abnormality in AVP secretion and thirst was corrected after glucocorticoid replacement with normalization of plasma sodium concentrations and osmolality. Thus, glucocorticoid deficiency in man results in a clinical picture almost indistinguishable from that of the syndrome of inappropriate secretion of antidiuretic hormone. Persistent AVP secretion in this pathological state is due to a loss of hypotonic suppression of the osmostat for AVP release, which may be occasioned primarily by glucocorticoid deficiency per se and aggravated secondarily by multiple nonosmotic stimuli including nausea, hypotension, and hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263145     DOI: 10.1210/jcem.77.6.8263145

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Hyponatraemia and hypernatraemia: pitfalls in testing.

Authors:  W Stuart A Smellie; A Heald
Journal:  BMJ       Date:  2007-03-03

2.  Impact of etiology, age and gender on onset and severity of hyponatremia in patients with hypopituitarism: retrospective analysis in a specialised endocrine unit.

Authors:  Dragana Miljic; Mirjana Doknic; Marko Stojanovic; Marina Nikolic-Djurovic; Milan Petakov; Vera Popovic; Sandra Pekic
Journal:  Endocrine       Date:  2017-09-14       Impact factor: 3.633

Review 3.  Renal involvement in adrenal insufficiency (Addison disease): can we always recognize it?

Authors:  Claudia Fofi; Barbara Maresca; Silvia Altieri; Paolo Menè; Francescaromana Festuccia
Journal:  Intern Emerg Med       Date:  2019-10-17       Impact factor: 3.397

4.  Symptomatic hyponatremia as a presenting sign of hypothalamic-pituitary disease: a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like glucocorticosteroid responsive condition.

Authors:  D Olchovsky; D Ezra; I Vered; M Hadani; I Shimon
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

5.  Transient pseudo-hypoaldosteronism following resection of the ileum: normal level of lymphocytic aldosterone receptors outside the acute phase.

Authors:  M C Vantyghem; C Hober; A Evrard; A Ghulam; D Lescut; A Racadot; J P Triboulet; D Armanini; J Lefebvre
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

6.  Severe hyponatraemia with absence of hyperkalaemia in rapidly progressive Addison's disease.

Authors:  Michael D Thompson; Eileen Kalmar; Sasigarn A Bowden
Journal:  BMJ Case Rep       Date:  2015-05-28

7.  Very delayed hyponatremia after surgery and radiotherapy for a pituitary macroadenoma.

Authors:  M Filippella; P Cappabianca; L M Cavallo; A Faggiano; G Lombardi; Divitiis E de; A Colao
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

Review 8.  Molecular mechanisms of urea transport in health and disease.

Authors:  Janet D Klein; Mitsi A Blount; Jeff M Sands
Journal:  Pflugers Arch       Date:  2012-09-25       Impact factor: 3.657

9.  A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis.

Authors:  Wiebke Kristin Fenske; Mirjam Christ-Crain; Anna Hörning; Jessica Simet; Gabor Szinnai; Martin Fassnacht; Jonas Rutishauser; Daniel G Bichet; Stefan Störk; Bruno Allolio
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

10.  Impairment of AVP regulation in 17alpha-hydroxylase deficiency, a unique form of adrenal insufficiency.

Authors:  A M O Leal; P C L Elias; A C Moreira
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.